Drug Trial News

RSS

Study explains exactly how exposure to lead during brain development produces learning deficits

A study of young adult rats by researchers from the Johns Hopkins Bloomberg School of Public Health provides evidence that explains exactly how exposure to lead during brain development produces learning deficits.

3 Apr 2007

Substantial need for mental health services in the general population

First large-scale assessment of the general population shows nearly 30 percent need mental health care and about one-third of them get it.

3 Apr 2007

Embolic protection and platelet inhibition during renal artery stenting

High blood pressure is the most common chronic medical condition in the United States, and the most common identifiable cause is narrowing of a kidney artery, called renal artery stenosis.

3 Apr 2007

Long-term safety of drug-eluting stents in off-label use

Research presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La, paints a picture of the "real world" use of drug-eluting stents and offers new insight into the connection between blood clotting, or thrombosis, in the stent - a dangerous complication - and adherence and responsiveness to anti-clotting medication.

3 Apr 2007

Advances in clinical cardiology

Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.

3 Apr 2007

Stem cell therapy shows promise for degenerative diseases of the eye

For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue.

3 Apr 2007

Sodium Bicarbonate vs. Sodium Chloride in persons undergoing coronary angiography

In patients undergoing cardiac catheterization, contrast dye injection can sometimes cause contrast-induced nephropathy (CIN), otherwise known as acute renal failure.

3 Apr 2007

Preventive health examinations may provide opportunities for cancer screening

Health plan members who receive preventive health examinations, as opposed to going to a physician only when they are sick, appear more likely to undergo testing for colorectal, breast and prostate cancers, according to a report in the March 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

3 Apr 2007

Where you live might play a bigger role in your risk for heart disease than your ethnicity or race

New research reveals that rural residents were more knowledgeable about healthy eating and heart disease risk than urban residents, but that urban residents were more motivated and optimistic about getting healthy.

3 Apr 2007

Physicians may be obstacles to breast reconstruction

Significant differences in plastic surgery referral practices by general surgeons treating newly diagnosed breast cancer patients partially explain the low rates of breast reconstructive surgery in the United States, according to a new study.

3 Apr 2007

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

Percutaneous coronary interventions (PCI) involve opening partially blocked arteries to improve blood flow to the heart. These procedures are performed more than 1 million times a year.

3 Apr 2007

Effective postoperative pain control using continuous peripheral nerve block reduces days of hospitalization

Effective postoperative pain control using continuous peripheral nerve block reduced average length-of-stay by nearly a day, University of Pittsburgh School of Medicine physicians reported today during the 81st Clinical and Scientific Congress of the International Anesthesia Research Society at the Buena Vista Palace in Orlando, Fla.

3 Apr 2007

We need to balance out our intake of omega-6 and omega-3 fatty acids

A new study suggests that people whose diets contain dramatically more of one kind of polyunsaturated fatty acid than another may be at greater risk for both clinical depression and certain inflammatory diseases.

3 Apr 2007

Regular health exams increase likelihood that older adults will get recommended cancer screenings

If you're 50 or older, seeing your doctor every year or two for a checkup may be a good defense against cancer, according to a new study by researchers at UC Davis, the University of Washington, and Group Health Cooperative in Seattle.

2 Apr 2007

H63D genetic defect linked to increased risk of stroke

One of the most common genetic defects passed on through families significantly increases a person's chance of having a stroke, according to a study published in the March 27, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.

2 Apr 2007

Dual renin system blocking drug combo provides additional blood pressure-lowering effects

A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, according to a study presented today at the American College of Cardiology's 56th Annual Scientific Session.

2 Apr 2007

$Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock$

Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock

Patients with acute coronary syndromes (ACS), such as heart attack and recent-onset chest pain, remain at considerable risk of experiencing further serious cardiovascular problems despite improvements in care.

2 Apr 2007

Tilarginine does not reduce risk of death after heart attack

The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.

2 Apr 2007

Effect of Torcetrapib on the progression of coronary atherosclerosis

Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).

2 Apr 2007

Addition of torcetrapib to statin therapy has no benefit for atherosclerosis progression

For some patients with high cholesterol, even the most aggressive treatment with statin drugs fails to prevent coronary artery disease.

2 Apr 2007

Drug Trial News

Study explains exactly how exposure to lead during brain development produces learning deficits

Substantial need for mental health services in the general population

Embolic protection and platelet inhibition during renal artery stenting

Long-term safety of drug-eluting stents in off-label use

Advances in clinical cardiology

Stem cell therapy shows promise for degenerative diseases of the eye

Sodium Bicarbonate vs. Sodium Chloride in persons undergoing coronary angiography

Preventive health examinations may provide opportunities for cancer screening

Where you live might play a bigger role in your risk for heart disease than your ethnicity or race

Physicians may be obstacles to breast reconstruction

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

Effective postoperative pain control using continuous peripheral nerve block reduces days of hospitalization

We need to balance out our intake of omega-6 and omega-3 fatty acids

Regular health exams increase likelihood that older adults will get recommended cancer screenings

H63D genetic defect linked to increased risk of stroke

Dual renin system blocking drug combo provides additional blood pressure-lowering effects

Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock

Tilarginine does not reduce risk of death after heart attack

Effect of Torcetrapib on the progression of coronary atherosclerosis

Addition of torcetrapib to statin therapy has no benefit for atherosclerosis progression

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News